Pictet Asset Management (UK)’s Flexion Therapeutics, Inc. FLXN Stock Holding History

Pictet Asset Management (UK)’s Portfolio FLXN Stock Details FLXN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-1,432,159	Closed	-$17.9M	–	1056
2019 Q1	$17.9M	Buy	1,432,159 +8,139	+0.6%	+$109K	0.04%	425
2018 Q4	$16.1M	Buy	1,424,020 +61,849	+5%	+$970K	0.04%	414
2018 Q3	$25.5M	Buy	1,362,171 +131,115	+11%	+$3.01M	0.05%	366
2018 Q2	$31.8M	Sell	1,231,056 -38,402	-3%	-$997K	0.08%	303
2018 Q1	$28.4M	Buy	1,269,458 +115,839	+10%	+$2.83M	0.07%	323
2017 Q4	$28.9M	Buy	1,153,619 +549,150	+91%	+$13.4M	0.07%	316
2017 Q3	$14.6M	Buy	604,469 +131,673	+28%	+$3.1M	0.04%	418
2017 Q2	$8.08M	Buy	472,796 +200,657	+74%	+$4.18M	0.02%	512
2017 Q1	$7.32M	Buy	+272,139	New	+$5.56M	0.02%	530

Other funds holding FLXN

MVP

Miller Value Partners Sarasota, Florida $423M AUM 49.14% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Schroder Investment Management Group London, United Kingdom $141B AUM 34.18% 1-Year Est. Return

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

TGHSA

TPG Group Holdings (SBS) Advisors Fort Worth, Texas $10.1B AUM 22.58% 1-Year Est. Return

Pictet Asset Management (UK)'s FLXN Position: Q2 2019 in Review

Pictet Asset Management (UK) sold out of Flexion Therapeutics, Inc. (FLXN) in Q2 2019, closing a stake of 1,432,159 shares — an estimated $17.9M sold.

Pictet Asset Management (UK) first reported a position in FLXN in Q1 2017 and held it in 9 quarters. The position peaked at $31.8M in Q2 2018. 129 funds tracked by Wall St. Rank hold FLXN as of Q2 2019.

Pictet Asset Management (UK) reported no remaining Flexion Therapeutics, Inc. position as of Q2 2019 after selling out during the quarter.
Pictet Asset Management (UK) sold 1,432,159 Flexion Therapeutics, Inc. shares in Q2 2019, an estimated $17.9M.
Pictet Asset Management (UK) first reported a position in Flexion Therapeutics, Inc. in Q1 2017 and held it in 9 quarters.
Pictet Asset Management (UK)'s Flexion Therapeutics, Inc. position peaked at $31.8M in Q2 2018.
129 funds tracked by Wall St. Rank held Flexion Therapeutics, Inc. as of Q2 2019.

Based on Pictet Asset Management (UK)'s 13F filing for Q2 2019, filed 13 Aug 2019.